ProQR Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.About PRQR
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.
PRQR Key Statistics
Stock Snapshot
The current ProQR Therapeutics(PRQR) stock price is $1.75, with a market capitalization of 184.86M. The stock trades at a price-to-earnings (P/E) ratio of -3.83.
As of 2026-01-24, ProQR Therapeutics(PRQR) stock has fluctuated between $1.68 and $1.80. The current price stands at $1.75, placing the stock +4.2% above today's low and -2.5% off the high.
The ProQR Therapeutics(PRQR)'s current trading volume is 508.59K, compared to an average daily volume of 579.58K.
During the past year, ProQR Therapeutics(PRQR) stock moved between $1.07 at its lowest and $3.10 at its peak.
During the past year, ProQR Therapeutics(PRQR) stock moved between $1.07 at its lowest and $3.10 at its peak.
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.